# Yunji Inc.: financial statements, quarterly

YJ · Nasdaq · CIK 1759614 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yj.md) · [Financials](/companies/yj/financials.md) · [Filings](/companies/yj/filings.md) · [Insiders](/companies/yj/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yj/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [127](/filings/0001193125-20-118175.md) | [163](/filings/0001193125-21-130439.md) | [89.0](/filings/0001193125-22-119026.md) | [60.1](/filings/0001193125-23-116482.md) | [72.9](/filings/0001493152-24-015848.md) | [30.1](/filings/0001641172-25-005915.md) | [15.7](/filings/0001493152-26-018839.md) |
| Current assets | $m | [411](/filings/0001193125-20-118175.md) | [329](/filings/0001193125-21-130439.md) | [268](/filings/0001193125-22-119026.md) | [176](/filings/0001193125-23-116482.md) | [114](/filings/0001493152-24-015848.md) | [70.7](/filings/0001641172-25-005915.md) | [51.1](/filings/0001493152-26-018839.md) |
| Total assets | $m | [474](/filings/0001193125-20-118175.md) | [391](/filings/0001193125-21-130439.md) | [369](/filings/0001193125-22-119026.md) | [274](/filings/0001193125-23-116482.md) | [219](/filings/0001493152-24-015848.md) | [185](/filings/0001641172-25-005915.md) | [173](/filings/0001493152-26-018839.md) |
| Current liabilities | $m | [258](/filings/0001193125-20-118175.md) | [188](/filings/0001193125-21-130439.md) | [136](/filings/0001193125-22-119026.md) | [77.8](/filings/0001193125-23-116482.md) | [49.5](/filings/0001493152-24-015848.md) | [35.9](/filings/0001641172-25-005915.md) | [36.1](/filings/0001493152-26-018839.md) |
| Total liabilities | $m | [264](/filings/0001193125-20-118175.md) | [189](/filings/0001193125-21-130439.md) | [137](/filings/0001193125-22-119026.md) | [77.8](/filings/0001193125-23-116482.md) | [51.1](/filings/0001493152-24-015848.md) | [37.6](/filings/0001641172-25-005915.md) | [39.1](/filings/0001493152-26-018839.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [5.7](/filings/0001493152-26-018839.md) |
| Shareholders' equity | $m | [209](/filings/0001193125-20-118175.md) | [201](/filings/0001193125-21-130439.md) | [232](/filings/0001193125-22-119026.md) | [196](/filings/0001193125-23-116482.md) | [168](/filings/0001493152-24-015848.md) | [148](/filings/0001641172-25-005915.md) | [134](/filings/0001493152-26-018839.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.